Drug intelligence / Profile preview

alkaline glucosodiene

Development stage
Phase 1
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Oral
01

Overview

Alkaline glucosodiene is a novel compound described as an alkaline isomer or polymer of glucose, synthesized by reacting dextrose (glucose) with sodium bicarbonate. The resulting molecule, identified as 1-2-O-β-D-Glucopyranosyl-α-D-glucose (C12H22O11), forms a polymer through 1-2 linkages and exhibits properties distinct from native glucose. Its proposed mechanism of action targets cancer cell metabolism—specifically the Warburg effect—by exploiting cancer cells' high avidity for glucose. When taken up by tumor cells via their glucose transporters, the modified structure and alkalinity are hypothesized to disrupt cellular metabolism and pH balance, leading to selective cytotoxicity in cancerous tissue while sparing normal cells. Preclinical studies and early case reports suggest potential efficacy in solid tumors such as triple-negative breast cancer with bone metastasis; however, its chemical structure requires further validation and clinical evidence remains limited[1][3][4][5][6][7].

Other names
glucosodieneglucosodiene polymeralkaline glucose isomer
02

Targets

SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)

Beyond the preview

Go deeper on alkaline glucosodiene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alkaline glucosodiene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call